Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Allergy Asthma Proc. 2010 Jul-Aug;31(4):308-16. doi: 10.2500/aap.2010.31.3375.
To date, there are sparse data on epinephrine treatment for food-related anaphylaxis in adults. We sought to establish the frequency of more than one epinephrine treatment for adult patients who present with food-related anaphylaxis to the emergency department (ED). We performed a chart review, at two academic centers, of all adults presenting to the ED for food allergy (ICD9CM codes 693.1, 995.0, 995.1, 995.3, 995.7, 995.60-995.69, 558.3, 692.5, and 708.X) between January 1, 2001 and December 31, 2006. We focused on causative foods; treatments, including the number of epinephrine treatments given before and during the ED visit; and disposition. Through random sampling and appropriate weighting, the 486 reviewed cases represented a study cohort of 1286 patients. The median age was 36 years and the cohort was 62% women. Shellfish (23%), peanuts (12%), tree nuts (14%), and fish (14%) provoked the allergic reaction most commonly. Most patients (62%; 95% confidence interval [CI], 57-68%) met criteria for food-related anaphylaxis. In the ED, anaphylaxis patients received epinephrine (18%), antihistamines (91%), corticosteroids (81%), and inhaled albuterol (19%). Overall, 17% (95% CI, 9-25%) of patients with food-related anaphylaxis given epinephrine received >1 dose over the course of their reaction. Among anaphylaxis patients admitted to the hospital, only 10% included anaphylaxis in the discharge diagnosis. At ED discharge (82% of patients), 18% were referred to an allergist and 39% were prescribed self-injectable epinephrine. Among ED patients with food-related anaphylaxis treated with epinephrine, 17% were given >1 dose. This study supports the recommendation that patients at risk for food-related anaphylaxis should carry 2 doses of epinephrine.
迄今为止,成人因食物相关过敏反应而接受肾上腺素治疗的数据很少。我们旨在确定因食物相关过敏反应而到急诊室就诊的成年患者多次接受肾上腺素治疗的频率。我们在两个学术中心对 2001 年 1 月 1 日至 2006 年 12 月 31 日期间因食物过敏(ICD9CM 代码 693.1、995.0、995.1、995.3、995.7、995.60-995.69、558.3、692.5 和 708.X)到急诊室就诊的所有成年人进行了图表回顾。我们重点关注病因食物、治疗方法,包括在急诊就诊期间给予的肾上腺素治疗次数;以及处置情况。通过随机抽样和适当加权,审查的 486 例病例代表了一个 1286 例患者的研究队列。中位数年龄为 36 岁,队列中 62%为女性。贝类(23%)、花生(12%)、坚果(14%)和鱼类(14%)最常引发过敏反应。大多数患者(62%;95%置信区间[CI],57-68%)符合食物相关过敏反应的标准。在急诊室,过敏反应患者接受了肾上腺素(18%)、抗组胺药(91%)、皮质类固醇(81%)和吸入沙丁胺醇(19%)。总体而言,17%(95%CI,9-25%)接受肾上腺素治疗的食物相关过敏反应患者在反应过程中接受了超过 1 剂。在因过敏反应住院的患者中,只有 10%在出院诊断中包含过敏反应。在急诊室出院时(82%的患者),18%的患者被转介给过敏科医生,39%的患者被开具了自我注射肾上腺素的处方。在因食物相关过敏反应接受肾上腺素治疗的急诊室患者中,17%的患者接受了超过 1 剂治疗。这项研究支持这样的建议,即有发生食物相关过敏反应风险的患者应携带 2 剂肾上腺素。